Emf6.1Fab treatment of hGP6tg/tg mice resulted in profound GPVI inhibition and protection from occlusive arterial thrombosis and thrombo-inflammatory cerebral infarct growth in experimental stroke, while not affecting tail bleeding times, even under conditions of complete receptor blockade (Structured Graphical Abstract ). This evidence concerns the gene GP6 and stroke disorder.